Diosbulbin D
CAS: 66756-57-8
Ref. 3D-RCA75657
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- (2S,4aS,6aS,7R,10R,11aR,11bS)-2-(3-Furanyl)octahydro-11b-methyl-7,10-methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione
- 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, (2S,4aS,6aS,7R,10R,11aR,11bS)-
- 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, [2S-(2α,4aβ,6aα,7α,10α,11aβ,11bα)]-
- NSC 310637
- Neodiosbulbin
Diosbulbin D is a tetrahydrocannabinol (THC) derivative that has been identified as a matrix effect agent. It is a potent, selective and orally active inhibitor of the enzyme fatty acid amide hydrolase (FAAH). Diosbulbin D selectively blocks the hydrolysis of anandamide and other endocannabinoids, which are lipid-signaling molecules produced by the body. This prevents their degradation, leading to increased levels of these compounds in the body. The effects of this drug have been analyzed using LC-MS/MS method on bladder cancer cells, pancreatic cancer cells and skin cancer cells. The results suggest that it may be an effective treatment for cancers characterized by elevated FAAH levels.
Propiedades químicas
Consulta técnica sobre: 3D-RCA75657 Diosbulbin D
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
